1. HBW Insight
  2. >>Geography
  3. >>North America
  4. >>United States

Syphilis OTC Test Developer NOWDiagnostics Raises $22.5M

 
• By Ryan Nelson

The Series B funding round led by DigitalDx Ventures will support development and commercialization of more than 30 rapid diagnostic tests in NOWDx’s clinical research pipeline, including its First To Know Syphilis OTC test, currently under US FDA De Novo review, which provides at-home results in minutes.

NOWDx entered a de novo classification request to the US FDA for its Syphilis OTC test in January. • Source: Shutterstock

[Editor's note: This article appeared first in our sister publication, Medtech Insight.]

NOWDiagnostics, Inc. aims to accelerate the development and commercialization of at-home diagnostic tests with $22.5m in series B funding, announced on 9 July.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America